Autolus Therapeutics to report second quarter 2023 financial results and host conference call on August 3, 2023
18 7월 2023 - 8:00PM
Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage
biopharmaceutical company developing next-generation programmed T
cell therapies, today announced that it will release its second
quarter 2023 financial results and operational highlights before
open of US markets on Thursday, August 3, 2023.
Management will host a conference call and
webcast at 8:30 am EDT/1:30 pm BST to discuss the company’s
financial results and provide a general business update. Conference
call participants should pre-register using this link to
receive the dial-in numbers and a personal PIN, which are required
to access the conference call.
A simultaneous audio webcast and replay will be
accessible on the events section of Autolus’ website.
Contact:
Julia Wilson+44 (0) 7818
430877j.wilson@autolus.com
Susan A. NoonanS.A. Noonan
Communications+1-917-513-5303susan@sanoonan.com
Alexandra Deschner+
+32-490-58-35-23a.deschner@autolus.com
Autolus Therapeutics (NASDAQ:AUTL)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Autolus Therapeutics (NASDAQ:AUTL)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
